Profile
YYZ Pharmatech Inc. (“YYZ”) is a deep tech company endeavoring to profoundly progress new medicine for patients by revealing the plasma proteome. Plasma is notoriously complex but contains the most biologically relevant proteins and peptides when derived from human patients. YYZ has pioneered technologies to discover, validate and assay the most elusive low-abundance proteins and peptides. This unprecedented lens into the plasma proteome unlocks new fluid biomarkers, attractive cell-surface co-receptor drug targets, and highly-specific biomolecules.
YYZ’s key objective is to identify world-class pharma collaborators to progress multi-specific antibody and peptide therapies against novel cell-surface co-receptor drug targets discovered by YYZ in oncology, immunology and metabolic disorders.
Website
yyzpharmatech.comContact
-
Mike Badeau, President and Chief Executive OfficerTel: +1 416-400-9213Email: mbadeau@yyzpharmatech.com
-
-
-
-
-
Event details
Event contact
Participants
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for… -
BioBackers is a nascent investor intelligence platform for therapeutics companies raising capital. The platform… -
BioScript Solutions is a Canadian healthcare company committed to simplifying access to specialty care. It… -
Bough Biosciences is a pre-seed stage biotech focused on the development of a therapy for treatment resistant… -
HDAX Therapeutics, a biotechnology company pioneering a novel approach to target… -
iCLASS is a revolutionary TechBIO company merging multi-proteomics-centered data generation with next-generation… -
Intrepid Labs revolutionizes drug formulation with Valiant™, an AI-driven robotic lab that explores… -
JN Nova Pharma is Canadian biotech company which has worked with National Research Council of Canada… -
Noa Therapeutics is pioneering a novel biased signal approach to AhR… -
Pattern’s patented PPI-100 activates innate immunity against cancers… -
PlantForm Corporation is a biopharmaceutical company focused on the rapid development and production of specialty… -
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead… -
Q&C Services is Canada’s largest independent full-service consultant and importer for pharmaceutical, natural… -
QurCan Therapeutics is advancing the next wave of genetic medicines for CNS… -
Rhythm Biotherapeutics develops first-in-class, heart-derived exosome therapeutics to prevent atrial fibrillation… -
Singularity Pharma is a drug discovery business developing novel therapeutics for… -
Specific Biologics is developing Dualase®, an industry-leading genome editing platform with best-in-class… -
Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number… -
TheraVac Biologics is a late-stage preclinical company developing innovative immunotherapies for… -
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide… -
Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the… -
YYZ Pharmatech Inc. (“YYZ”) is a deep tech company endeavoring to profoundly progress new medicine…